Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells
It is well known that gold nanoparticle is one of the several metal nanoparticles approved for clinical trial by American FDA. This work has demonstrated the outstanding PTT and immunotherapeutic effects of gold nanoparticle complexes on NSCLC, indicating great potential in clinical regiment of lung cancers.
Authors
- Fang‐Cheng Jiang (ORCID: https://orcid.org/0000-0002-2361-9362)
- Rong‐Quan He (ORCID: https://orcid.org/0000-0002-7752-2080)
- Lihua Yang (ORCID: https://orcid.org/0000-0003-2570-076X)
- Li Gao (ORCID: https://orcid.org/0000-0001-8762-6804)
- Gang Chen (ORCID: https://orcid.org/0000-0003-2402-2987)
- Jinliang Kong (ORCID: https://orcid.org/0000-0003-4065-7886)
- Zefeng Lai (ORCID: https://orcid.org/0000-0003-2352-0570)
- Wangyang Ye
- Xin Chen (ORCID: https://orcid.org/0000-0002-1224-0285)
- Wan‐Ying Huang (ORCID: https://orcid.org/0000-0003-0461-7182)
- Zhen‐Bo Feng (ORCID: https://orcid.org/0000-0001-6361-4198)
- Zhongfan Liu (ORCID: https://orcid.org/0000-0001-5554-1902)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-07-01
- DOI
- https://doi.org/10.2147/ijn.s518427
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.72